Your Business Your Retirement? Solo 401(k) Deadline Looms
Solopreneurs risk treating their business as retirement, but a year-end Solo 401K deadline offers a tax-advantaged pa...
Wash-sale considerations when replacing dividend ETF protect your tax position. This guide outlines rule basics, look-back periods, and compliant practices.
13,645 articlesSolopreneurs risk treating their business as retirement, but a year-end Solo 401K deadline offers a tax-advantaged pa...
A new class of buffer ETFs promises protection for the first 15% of losses while chasing stock gains without stress? ...
With savings yields retreating as the Fed eases policy, two utility ETFs offer a compelling mix of income and upside....
AMLP delivered a record May 2026 payout and a 14% trailing return, underscoring resilient midstream cash flow. Invest...
As investors pivot away from high-flying tech, the financial sector could offer underappreciated value. This guide ex...
Novo Nordisk isn’t in the spotlight, but its steady cash flow and strong pipeline could unlock long-term gains. This ...
When a big fund trims a REIT stake, investors watch for clues about rental income and stock performance. This article...
Diplomacy with Iran could spark big moves in oil this week. If talks gain momentum, prices could ease; if they stall,...
In 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
Bear markets are scary, but they also reveal high-quality opportunities. This guide shows which market crash: financi...
When the market hears that the federal reserve just delivered a hawkish message, a storm of headlines follows. This g...
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...